Pyrroloquinoline quinone attenuates cachexia-induced muscle atrophy via suppression of reactive oxygen species
Introduction
Cachexia, a wasting syndrome, is most commonly observed in the majority of patients with advanced cancer including lung cancer, liver cancer, gastric cancer, renal cancer, etc. (1-3).
